| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101175531B Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol |
| 09/07/2011 | CN101175474B Methods of reducing microbial contamination |
| 09/06/2011 | US8013022 Stabilized products, process and devices for preparing same |
| 09/06/2011 | US8013020 1-adamantyl chalcones for the treatment of proliferative disorders |
| 09/06/2011 | US8013017 Dermatological compositions and methods |
| 09/06/2011 | US8012954 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| 09/06/2011 | US8012944 Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent |
| 09/06/2011 | US8012934 Small peptides and methods for treatment of inflammation |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012711 Methods of screening for compounds that reduce microbial resistance to fluoroquinolones |
| 09/06/2011 | US8012681 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody |
| 09/06/2011 | US8012494 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/06/2011 | US8012475 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | US8012463 Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 09/06/2011 | CA2495454C Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics |
| 09/06/2011 | CA2493536C 8-hydroxy quinoline derivatives |
| 09/06/2011 | CA2488642C Aryl carbonyl derivatives as glucokinase activators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2452260C Novel variants and exons of the glyt1 transporter |
| 09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/02/2011 | WO2010097344A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/02/2011 | CA2784516A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/01/2011 | WO2011106545A1 Polyimidazoles for use as bile acid sequestrants |
| 09/01/2011 | WO2011105551A1 Method for detection of cancer stem cell, and therapeutic agent or recurrence-preventing agent for cancer |
| 09/01/2011 | WO2011105527A1 Nerve growth promoter |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011105383A1 Agent for controlling production of primary bile acid and secondary bile acid |
| 09/01/2011 | WO2011104971A1 Composition for controlling weight gain and food product containing the same |
| 09/01/2011 | WO2011104562A1 Fungal nail treatment composition |
| 09/01/2011 | WO2011104161A1 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field |
| 09/01/2011 | US20110213136 Antisense modulation of stearoyl-coa desaturase expression |
| 09/01/2011 | US20110212972 Compositions and Methods for Treating Female Sexual Dysfunction |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212188 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 09/01/2011 | DE10320604B4 Partikel umfassend ein Biopolymer, das unter Einwirkung von elektromagnetischen Wellen, ausgestrahlt durch Sonneneinstrahlung, abbaubar ist Particles comprising a biopolymer that is under the influence of electromagnetic waves emitted by the sun, degradable |
| 09/01/2011 | CA2790959A1 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti-inflammatory agent for the treatment of inflammation and pain in the veterinary field |
| 09/01/2011 | CA2790899A1 Polyimidazoles for use as bile acid sequestrants |
| 09/01/2011 | CA2790817A1 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |
| 08/31/2011 | EP2361981A1 RNA sequence-specific mediators of RNA interference |
| 08/31/2011 | EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 08/31/2011 | EP2361922A1 Intermediate to HCV-Nucleoside Inhibitors |
| 08/31/2011 | EP2361629A1 Prevention and treatment of synucleinopathic disease |
| 08/31/2011 | EP2361626A1 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 08/31/2011 | EP2361622A1 Use of lipoxin analogs to promote cell defense against gram-negative infections |
| 08/31/2011 | EP2361620A1 Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome |
| 08/31/2011 | EP2361609A1 Sustained release small molecule drug formulation |
| 08/31/2011 | EP2361090A1 Compositions for treating centrally mediated nausea and vomiting |
| 08/31/2011 | EP2361087A1 Anti-inflammatory compounds and compositions thereof |
| 08/31/2011 | EP2361085A2 Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer |
| 08/31/2011 | EP2193204B1 Compositions comprising lipophosphoramides and their uses in gene therapy |
| 08/31/2011 | EP2117564B1 Use of chitosans to increase nail growth rate |
| 08/31/2011 | EP2102331B1 Anti-tumor vaccine derived from normal chemically modified cd4+ cells |
| 08/31/2011 | EP1634589B9 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/31/2011 | EP1523325B1 Methods and compositions for treating polycystic ovary syndrome |
| 08/31/2011 | EP1521754B1 Viral inhibitors |
| 08/31/2011 | EP1467712B2 Method of producing a bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide |
| 08/31/2011 | EP1401498B1 Anti-ngf antibodies for the treatment of various disorders |
| 08/31/2011 | EP1339394B1 Pharmaceutical preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 08/31/2011 | CN1976679B Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 08/31/2011 | CN1824289B Use of substance P for mobilization or proliferation of mesenchymal stem cells and for wound healing or accelerating wound healing |
| 08/31/2011 | CN1433314B Antimicrobial compositions and methods of use |
| 08/31/2011 | CN102170911A Methods for treating reperfusion injuries |
| 08/31/2011 | CN102170910A Novel use application of sugar chain-recognizing receptor |
| 08/31/2011 | CN102170873A Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 08/31/2011 | CN102170870A An extended release pharmaceutical composition of entacapone or salts thereof |
| 08/31/2011 | CN102170869A Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
| 08/31/2011 | CN102166364A Inhibitor of calcium-independent phospholipase A2 used for treating oophoroma |
| 08/31/2011 | CN102166359A Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 08/31/2011 | CN102166358A Use of inhibitors of jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN101698101B Medicine composite for treating vaginitis |
| 08/31/2011 | CN101450208B Nasal-spraying immune influenza multivalent vaccine preparation method |
| 08/30/2011 | US8008442 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 08/30/2011 | US8008345 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 08/30/2011 | US8008333 Inducing ovulation; increasing response to follicle stimulating hormone |
| 08/30/2011 | US8008330 Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/30/2011 | US8008323 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/30/2011 | US8008281 Methods for the treatment of cancer |
| 08/30/2011 | US8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 08/30/2011 | US8008270 Antiviral oligonucleotides targeting viral families |
| 08/30/2011 | US8008269 Antiviral oligonucleotides |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008077 Photochemical internalization for delivery of molecules into the cytosol |
| 08/30/2011 | US8007853 Vitamin/mineral composition with DHA |
| 08/30/2011 | US8007816 Yeast-based therapeutic for chronic hepatitis C infection |
| 08/30/2011 | US8007806 Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007789 Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/30/2011 | CA2493883C Drugs for improving the prognosis of brain injury and a method of screening the same |
| 08/30/2011 | CA2489259C Polymeric micelle complexes of low molecular weight antitumor agents and styrene maleic acid copolymers |
| 08/30/2011 | CA2479665C Nanoparticulate compositions of angiogenesis inhibitors |
| 08/30/2011 | CA2460911C 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
| 08/30/2011 | CA2459757C Combination |
| 08/30/2011 | CA2415927C Dietary lipids for improving skin and coat of pets |